(Q36217916)

12 August 2017

1 reference

title

Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders (English)

1 reference

12 August 2017

Houghton LA

1

1 reference

12 August 2017

Whorwell PJ

series ordinal

2

1 reference

12 August 2017

language of work or name

1 reference

1 August 2005

1 reference

Neurogastroenterology and Motility

12 August 2017

published in

1 reference

12 August 2017

volume

17

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

500-511

1 reference

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Review article: bloating in functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Abdominal distension after colonic lactulose fermentation recorded by a new extensometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

A device for 24 hour ambulatory monitoring of abdominal girth using inductive plethysmography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

An Irritable Bowel Syndrome-Specific Symptom Questionnaire: Development and Validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Hysterical type of nongaseous abdominal bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Sites of symptomatic gas retention during intestinal lipid perfusion in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Gastric distension and duodenal lipid infusion modulate intestinal gas transit and tolerance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Intestinal gas distribution determines abdominal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Cellular Mechanisms of Prostaglandin Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Cutaneous reactions to intradermal prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Bloated irritable bowel syndrome defined by dynamic 99mTc bran scan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Bran and irritable bowel syndrome: time for reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Does lactose maldigestion really play a role in the irritable bowel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

The putative role of inflammation in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Methane production during lactulose breath test is associated with gastrointestinal disease presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Failure of activated charcoal to reduce the release of gases produced by the colonic flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Long term benefits of hypnotherapy for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Long-term improvement in functional dyspepsia using hypnotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00666.X

10.1111/J.1365-2982.2005.00666.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference